• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管癌进展中的肿瘤微环境。

The Tumor Microenvironment in Cholangiocarcinoma Progression.

机构信息

Department of Molecular Medicine, University of Padua, Padua, Italy.

Liver Center and Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.

出版信息

Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):75-85. doi: 10.1002/hep.31410. Epub 2020 Nov 6.

DOI:10.1002/hep.31410
PMID:32500550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7714713/
Abstract

Cholangiocarcinoma (CCA) is an aggressive and heterogeneous malignancy of the biliary tree. A typical hallmark of CCA is that cancer cells are embedded into a dense stroma containing fibrogenic cells, lymphatics and a variety of immune cells. Functional roles of the reactive tumor stroma are not fully elucidated; however, recent studies suggest that the tumor microenvironment plays a key role in the progression and invasiveness of CCA. CCA cells exchange autocrine/paracrine signals with other cancer cells and the infiltrating cell types that populate the microenvironment. This crosstalk is under the control of signals mediated by various cytokines, chemokines, and growth factors. In addition, extracellular vesicles (EVs), exosomes and microvesicles, containing cargo mediators, such as proteins and RNAs, play a key role in cell-to-cell communication, and particularly in epigenetic regulation thanks to their content in miRNAs. Both cytokine- and EV-mediated communications between CCA cells and other liver cells provide a potential novel target for the management of CCA. This review summarizes current understandings of the tumor microenvironment and intercellular communications in CCA and their role in tumor progression.

摘要

胆管癌(CCA)是一种侵袭性和异质性的胆道恶性肿瘤。CCA 的一个典型特征是癌细胞嵌入到富含成纤维细胞、淋巴管和各种免疫细胞的致密基质中。反应性肿瘤基质的功能作用尚未完全阐明;然而,最近的研究表明,肿瘤微环境在 CCA 的进展和侵袭性中起着关键作用。CCA 细胞与其他癌细胞以及浸润微环境的细胞类型交换自分泌/旁分泌信号。这种串扰受各种细胞因子、趋化因子和生长因子介导的信号控制。此外,含有货物介质(如蛋白质和 RNA)的细胞外囊泡(EVs)、外泌体和微泡在细胞间通讯中发挥关键作用,特别是由于其 miRNA 含量在表观遗传调控中发挥作用。CCA 细胞与其他肝细胞之间的细胞因子和 EV 介导的通讯为 CCA 的管理提供了一个潜在的新靶点。本综述总结了目前对 CCA 中肿瘤微环境和细胞间通讯及其在肿瘤进展中的作用的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ad/7714713/6d88bb8f9f39/nihms-1615239-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ad/7714713/9163bc683601/nihms-1615239-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ad/7714713/b989eb52074d/nihms-1615239-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ad/7714713/72f10ea2c6eb/nihms-1615239-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ad/7714713/6d88bb8f9f39/nihms-1615239-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ad/7714713/9163bc683601/nihms-1615239-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ad/7714713/b989eb52074d/nihms-1615239-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ad/7714713/72f10ea2c6eb/nihms-1615239-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03ad/7714713/6d88bb8f9f39/nihms-1615239-f0004.jpg

相似文献

1
The Tumor Microenvironment in Cholangiocarcinoma Progression.胆管癌进展中的肿瘤微环境。
Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):75-85. doi: 10.1002/hep.31410. Epub 2020 Nov 6.
2
Significance of the Tumor Microenvironment in Liver Cancer Progression.肿瘤微环境在肝癌进展中的意义。
Crit Rev Oncog. 2020;25(1):1-9. doi: 10.1615/CritRevOncog.2020034987.
3
Cancer-associated fibroblasts in cholangiocarcinoma.胆管癌中的癌相关成纤维细胞。
Curr Opin Gastroenterol. 2020 Mar;36(2):63-69. doi: 10.1097/MOG.0000000000000609.
4
Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression.肿瘤相关巨噬细胞:胆管癌进展的协调者。
Front Immunol. 2024 Sep 3;15:1451474. doi: 10.3389/fimmu.2024.1451474. eCollection 2024.
5
Programmed death ligand-1, tumor infiltrating lymphocytes and HLA expression in Chinese extrahepatic cholangiocarcinoma patients: Possible immunotherapy implications.程序性死亡配体-1、肿瘤浸润淋巴细胞和 HLA 表达在中国人肝外胆管癌患者中的意义:可能的免疫治疗启示。
Biosci Trends. 2019 Mar 14;13(1):58-69. doi: 10.5582/bst.2019.01003. Epub 2019 Feb 15.
6
Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status.肥胖是肝内胆管癌进展的一个风险因素,与代谢活性和免疫状态的改变有关。
Sci Rep. 2021 Mar 12;11(1):5845. doi: 10.1038/s41598-021-85186-6.
7
Highlights of topic "Etiology and epidemiology of cholangiocarcinoma".“胆管癌的病因学与流行病学”主题要点
J Hepatobiliary Pancreat Sci. 2014 May;21(5):299-300. doi: 10.1002/jhbp.90.
8
SnapShot: Cancer-Associated Fibroblasts.快照:癌症相关成纤维细胞。
Cell. 2020 Apr 16;181(2):486-486.e1. doi: 10.1016/j.cell.2020.03.013.
9
MA Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.MA 去甲基化酶 ALKBH5 调控肝内胆管癌中 PD-L1 的表达和肿瘤免疫微环境。
Cancer Res. 2021 Sep 15;81(18):4778-4793. doi: 10.1158/0008-5472.CAN-21-0468. Epub 2021 Jul 23.
10
[Intrahepatic cholangiocarcinoma associated with viral hepatitis].[与病毒性肝炎相关的肝内胆管癌]
Nihon Shokakibyo Gakkai Zasshi. 2012 Nov;109(11):1872-7.

引用本文的文献

1
Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut-Liver Axis in Tumorigenesis and Therapy.肝癌中的基因组改变与微生物群串扰:肿瘤发生与治疗中的肠-肝轴
Genes (Basel). 2025 Jul 30;16(8):920. doi: 10.3390/genes16080920.
2
Single-cell transcriptome sequencing reveals tumor stem cells and their molecular characteristics in intrahepatic cholangiocarcinoma.单细胞转录组测序揭示肝内胆管癌中的肿瘤干细胞及其分子特征。
Sci Rep. 2025 Aug 25;15(1):31170. doi: 10.1038/s41598-025-17102-1.
3
Preoperative prediction model of microvascular invasion in intrahepatic cholangiocarcinoma patients based on CT radiomics can assist clinical surgical decision-making: a multicenter study.

本文引用的文献

1
Liver Matrix in Benign and Malignant Biliary Tract Disease.肝脏基质在良性和恶性胆道疾病中的作用。
Semin Liver Dis. 2020 Aug;40(3):282-297. doi: 10.1055/s-0040-1705109. Epub 2020 Mar 11.
2
Cholangiocarcinoma: novel therapeutic targets.胆管癌:新的治疗靶点。
Expert Opin Ther Targets. 2020 Apr;24(4):345-357. doi: 10.1080/14728222.2020.1733528. Epub 2020 Feb 26.
3
Immunobiology of cholangiocarcinoma.胆管癌的免疫生物学
基于CT影像组学的肝内胆管癌患者微血管侵犯术前预测模型可辅助临床手术决策:一项多中心研究
Eur Radiol. 2025 Aug 14. doi: 10.1007/s00330-025-11900-x.
4
Recent progress in the study of exosomes in the gastric cancer immune microenvironment.胃癌免疫微环境中细胞外囊泡研究的最新进展
Front Immunol. 2025 Jul 23;16:1595124. doi: 10.3389/fimmu.2025.1595124. eCollection 2025.
5
Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy.肿瘤免疫调节中的细胞外基质动态变化:从肿瘤微环境到免疫治疗
J Hematol Oncol. 2025 Jun 19;18(1):65. doi: 10.1186/s13045-025-01717-y.
6
Prognosis of cholangiocarcinoma patients based on multiple patterns of programmed cell death, integrated analysis of the immune microenvironment and drug sensitivity.基于多种程序性细胞死亡模式的胆管癌患者预后、免疫微环境综合分析及药物敏感性
Front Genet. 2025 May 14;16:1457204. doi: 10.3389/fgene.2025.1457204. eCollection 2025.
7
Causal role of immune cells in primary liver cancer: a mendelian randomization study.免疫细胞在原发性肝癌中的因果作用:一项孟德尔随机化研究
BMC Cancer. 2025 May 23;25(1):928. doi: 10.1186/s12885-025-14327-1.
8
Tumor diagnosis recharacterization enabled by comprehensive genomic profiling to guide precision medicine strategy.通过全面基因组分析实现肿瘤诊断重新特征化以指导精准医学策略。
NPJ Precis Oncol. 2025 May 21;9(1):149. doi: 10.1038/s41698-025-00942-5.
9
Investigating the causal relationship between the plasma lipidome and cholangiocarcinoma mediated by immune cells: a mediation Mendelian randomization study.探究免疫细胞介导的血浆脂质组与胆管癌之间的因果关系:一项中介孟德尔随机化研究
Sci Rep. 2025 Feb 17;15(1):5807. doi: 10.1038/s41598-025-90140-x.
10
Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma.用于评估胆管癌患者免疫治疗的生物标志物
Cancers (Basel). 2025 Feb 6;17(3):555. doi: 10.3390/cancers17030555.
JHEP Rep. 2019 Jul 10;1(4):297-311. doi: 10.1016/j.jhepr.2019.06.003. eCollection 2019 Oct.
4
Circulating osteopontin per tumor volume as a prognostic biomarker for resectable intrahepatic cholangiocarcinoma.每肿瘤体积的循环骨桥蛋白作为可切除性肝内胆管癌的预后生物标志物。
Hepatobiliary Surg Nutr. 2019 Dec;8(6):582-596. doi: 10.21037/hbsn.2019.03.14.
5
Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms.胆管癌的炎症与进展:血管生成和淋巴管生成机制的作用
Front Med (Lausanne). 2019 Dec 18;6:293. doi: 10.3389/fmed.2019.00293. eCollection 2019.
6
Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma.鉴定四种免疫亚型,其特点是肿瘤微环境的组成和功能明显不同,在肝内胆管癌中。
Hepatology. 2020 Sep;72(3):965-981. doi: 10.1002/hep.31092. Epub 2020 Aug 16.
7
Completely resolved advanced biliary tract cancer after treatment by pembrolizumab: a report of two cases.帕博利珠单抗治疗后完全缓解的晚期胆管癌:两例报告
Onco Targets Ther. 2019 Jul 4;12:5293-5298. doi: 10.2147/OTT.S197559. eCollection 2019.
8
Tumour-associated neutrophils in patients with cancer.癌症患者肿瘤相关中性粒细胞。
Nat Rev Clin Oncol. 2019 Oct;16(10):601-620. doi: 10.1038/s41571-019-0222-4.
9
The tumour microenvironment and immune milieu of cholangiocarcinoma.胆管癌的肿瘤微环境和免疫微环境。
Liver Int. 2019 May;39 Suppl 1(Suppl 1):63-78. doi: 10.1111/liv.14098.
10
Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology.胶原和癌症相关成纤维细胞在反应性基质中的作用及其与癌症生物学的关系。
J Exp Clin Cancer Res. 2019 Mar 6;38(1):115. doi: 10.1186/s13046-019-1110-6.